<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36282136</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-3038</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title><ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation></Journal><ArticleTitle>Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.</ArticleTitle><Pagination><StartPage>e13851</StartPage><MedlinePgn>e13851</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13851</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.13851</ELocationID><Abstract><AbstractText>By the April 12, 2022, the COVID-19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1&#xa0;million deaths directly due to the infection, but the pandemic has had many more short- and long-term pervasive effects on the physical and mental health of the population. Allergic diseases are among the most prevalent noncommunicable chronic diseases in the pediatric population, and health-care professionals and researchers were seeking answers since the beginning of pandemic. Children are at lower risk of developing severe COVID-19 or dying from infection. Allergic diseases are not associated with a higher COVID-19 severity and mortality, apart from severe/poorly controlled asthma. The pandemic disrupted routine health care, but many mitigation strategies, including but not limited to telemedicine, were successfully implemented to continue delivery of high-standard care. Although children faced a multitude of pandemic-related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies. There is no evidence to recommend substantial changes to usual management modalities of allergic conditions in children, including allergen immunotherapy and use of biologicals. Allergic children are not at greater risk of multisystem inflammatory syndrome development, but some associations with Long COVID were reported, although the data are limited, and further research is needed. This statement of the EAACI Section on Pediatrics provides recommendations based on the lessons learnt from the pandemic, as available evidence.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley &amp;amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9652-6856</Identifier><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenhawt</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2365-9372</Identifier><AffiliationInfo><Affiliation>Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brough</LastName><ForeName>Helen A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Children's Allergy Service, Evelina Children's Hospital, Guy's and St. Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushkareva</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karimova</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demidova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>John O</ForeName><Initials>JO</Initials><Identifier Source="ORCID">0000-0001-7123-6369</Identifier><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalayci</LastName><ForeName>Omer</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8715-5694</Identifier><AffiliationInfo><Affiliation>Pediatric Allergy and Asthma, School of Medicine, Hacettepe University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sediva</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology, 2nd Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Untersmayr</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez Del Rio</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Allergy Department, Hospital Infantil Universitario Ni&#xf1;o Jesus, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez-Ortiz</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arasi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8135-0568</Identifier><AffiliationInfo><Affiliation>Translational Research in Pediatric Specialities Area, Division of Allergy, IRCCS, Bambino Ges&#xf9; Children's Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvaro-Lozano</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allergology and Clinical Immunology Department, Institut de Recerca Sant Joan de D&#xe9;u, Hospital Sant Joan de D&#xe9;u, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsabouri</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7584-5401</Identifier><AffiliationInfo><Affiliation>Child Health Department, University of Ioannina School of Medicine, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6692-9101</Identifier><AffiliationInfo><Affiliation>Pediatric Allergology Unit, Department of Pediatric Medicine, S.Pietro Hospital Fatebenefratelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beken</LastName><ForeName>Burcin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7677-7690</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Allergy and Immunology, Acibadem University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eigenmann</LastName><ForeName>Philippe A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-1738-1826</Identifier><AffiliationInfo><Affiliation>Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Allergy Immunol</MedlineTA><NlmUniqueID>9106718</NlmUniqueID><ISSNLinking>0905-6157</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006967" MajorTopicYN="Y">Hypersensitivity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007153" MajorTopicYN="Y">Immunologic Deficiency Syndromes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MIS-C</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">allergic diseases</Keyword><Keyword MajorTopicYN="N">allergy</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">care</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">eczema</Keyword><Keyword MajorTopicYN="N">food allergy</Keyword><Keyword MajorTopicYN="N">immunodeficiencies</Keyword><Keyword MajorTopicYN="N">lockdown</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">post-covid-19 condition</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>DM reports receipt of grants from the British Embassy in Moscow, UK National Institute for Health Research (NIHR), and Russian Foundation for Basic Research for COVID&#x2010;19 and Long COVID research. He is also a cochair of International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Pediatric Long COVID Working Group, member of ISARIC working group on long&#x2010;term follow&#x2010;up in adults, co&#x2010;lead of the Post&#x2010;COVID Condition Core Outcomes (PC&#x2010;COS) project, chair of the Core Outcome Measures for Food Allergy (COMFA) consortium. MG is a consultant for Aquestive; is a member of physician/medical advisory boards for DBV Technologies, Sanofi/Regeneron, Nutricia, Novartis, Acquestive, Allergy Therapeutics, AstraZeneca, ALK&#x2010;Abello, and Prota, with all activity unrelated to vaccines/vaccine development or COVID&#x2010;19 treatment; is an unpaid member of the scientific advisory council for the National Peanut Board and medical advisory board of the International Food Protein Induced Enterocolitis Syndrome Association; is a member of the Brighton Collaboration Criteria Vaccine Anaphylaxis 2.0 working group; is the senior associate editor for the Annals of Allergy, Asthma, and Immunology, and is member of the Joint Taskforce on Allergy Practice Parameters. He has received honorarium for lectures from ImSci, MedLearningGroup, RMEI Medical Education, and multiple state/local allergy societies. He received past research support ending in 2020 from the Agency for Healthcare Quality and Research (K08&#x2010;HS024599). HB reports speaker honoraria from Sanofi, DBV Technologies, and GSK. PRR reports consulting fees from Miravo, FAES. Payment or honoraria for lectures from Aimmune Therapeutics, GSK, FAES, Novartis, ALK&#x2010;Abello, LETI Pharma, Sanofi, Stallergenes, and Miravo. SA reports honoraria for lectures from Ulrich. EU reports receipt of a research grant from Desentum Oy. JOW reports funding from Danone/Nutricia, Friesland&#x2010;Campina, and Airsonett. He also serves an Anaphylaxis Campaign clinical and scientific panel chairman and acknowledges travel expenses as a speaker covered by the World Allergy Organization. MAL received research funding from the Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP), the Catalan Society of Allergy and Clinical Immunology (SCAIC); reports honoraria for consultancy and/or advisory board and/or lectures from ALK&#x2010;Abello, FAES Pharma, LETI Pharma, Merck, Aimmune, DBV Technologies, Allergy Therapeutics, Stallergenes, Diater, Novartis, Uriach, Nestle, and Sanofi Genzyme. SA has participated as an advisory board member and/or consultant, and/or speaker for Novartis, and Ulrich outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36282136</ArticleId><ArticleId IdType="pmc">PMC9538373</ArticleId><ArticleId IdType="doi">10.1111/pai.13851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
The World Health Organization
. WHO coronavirus (COVID&#x2010;19) dashboard; 2022. Accessed April 8, 2022. https://covid19.who.int/
</Citation></Reference><Reference><Citation>Li J, Huang DQ, Zou B, et al. Epidemiology of COVID&#x2010;19: a systematic review and meta&#x2010;analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449&#x2010;1458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436673</ArticleId><ArticleId IdType="pubmed">32790106</ArticleId></ArticleIdList></Reference><Reference><Citation>Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid&#x2010;19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nekliudov NA, Bugaeva P, et al. Stop COVID cohort: an observational study of 3480 patients admitted to the Sechenov university hospital network in Moscow City for suspected coronavirus disease 2019 (COVID&#x2010;19) infection. Clin Infect Dis. 2021;73(1):1&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665333</ArticleId><ArticleId IdType="pubmed">33035307</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid&#x2010;19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi:10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne AB, Gilani Z, Godfred&#x2010;Cato S, et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS&#x2010;CoV&#x2010;2. JAMA Netw Open. 2021;4(6):e2116420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics &#x2013; the 2020 COVID&#x2010;19 pandemic: a statement from the EAACI&#x2010;section on pediatrics. Pediatr Allergy Immunol. 2020;31(5):442&#x2010;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264548</ArticleId><ArticleId IdType="pubmed">32319129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID&#x2010;19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020;323(13):1239&#x2010;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Demographic trends of COVID&#x2010;19 cases and deaths in the US reported to CDC; 2022. Accessed February 18, 2022. https://covid.cdc.gov/covid&#x2010;data&#x2010;tracker/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019&#x2010;ncov%2Fcases&#x2010;updates%2Fcases&#x2010;in&#x2010;us.html#demographics
</Citation></Reference><Reference><Citation>Oualha M, Bendavid M, Berteloot L, et al. Severe and fatal forms of COVID&#x2010;19 in children. Arch Pediatr. 2020;27(5):235&#x2010;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269941</ArticleId><ArticleId IdType="pubmed">32518045</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster CE, Moulton EA, Munoz FM, et al. Coronavirus disease 2019 in children cared for at Texas Children's Hospital: initial clinical characteristics and outcomes. J Pediatric Infect Dis Soc. 2020;9(3):373&#x2010;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313841</ArticleId><ArticleId IdType="pubmed">32504532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotzinger F, Santiago&#x2010;Garcia B, Noguera&#x2010;Julian A, et al. COVID&#x2010;19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653&#x2010;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim L, Whitaker M, O'Halloran A, et al. Hospitalization rates and characteristics of children aged &lt;18&#x2009;years hospitalized with laboratory&#x2010;confirmed COVID&#x2010;19 &#x2013; COVID&#x2010;NET, 14 states, March 1&#x2010;July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081&#x2010;1088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440125</ArticleId><ArticleId IdType="pubmed">32790664</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Nations Children's Fund
. Child mortality and COVID&#x2010;19; 2022. Accessed February 18, 2022. https://data.unicef.org/topic/child&#x2010;survival/covid&#x2010;19/
</Citation></Reference><Reference><Citation>
American Academy of Pediatrics
. Children and COVID&#x2010;19: state&#x2010;level data report; 2022. Accessed February 18, 2022. https://www.aap.org/en/pages/2019&#x2010;novel&#x2010;coronavirus&#x2010;covid&#x2010;19&#x2010;infections/children&#x2010;and&#x2010;covid&#x2010;19&#x2010;state&#x2010;level&#x2010;data&#x2010;report/
</Citation></Reference><Reference><Citation>Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin&#x2010;converting enzyme 2 in children and adults. Jama. 2020;323(23):2427&#x2010;2429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240631</ArticleId><ArticleId IdType="pubmed">32432657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatziparasidis G, Kantar A. COVID&#x2010;19 in children with asthma. Lung. 2021;199(1):7&#x2010;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835665</ArticleId><ArticleId IdType="pubmed">33496842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J, Thomas PG, Randolph AG. Immunology of SARS&#x2010;CoV&#x2010;2 infection in children. Nat Immunol. 2022;23(2):177&#x2010;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Dong X, Zhang JJ, et al. Clinical characteristics of 182 pediatric COVID&#x2010;19 patients with different severities and allergic status. Allergy. 2021;76(2):510&#x2010;532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307120</ArticleId><ArticleId IdType="pubmed">32524611</ArticleId></ArticleIdList></Reference><Reference><Citation>Beken B, Ozturk GK, Aygun FD, Aydogmus C, Akar HH. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(5):569&#x2010;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825986</ArticleId><ArticleId IdType="pubmed">33493639</ArticleId></ArticleIdList></Reference><Reference><Citation>Timberlake D, Scherzer R, Prince B, Grayson M. COVID&#x2010;19 severity in hospitalized pediatric patients with atopic disease. J Allergy Clin Immunol. 2021;147(2 Supplement):AB79.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Amat F, Delaisi B, Labbe JP, Leonardi J, Houdouin V. Asthma may not be a risk factor for severe COVID&#x2010;19 in children. J Allergy Clin Immunol Pract. 2021;9(6):2478&#x2010;2479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055445</ArticleId><ArticleId IdType="pubmed">33852880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao JY, Sugarman A, Kimura A, et al. Factors associated with hospitalization in children and adolescents with SARS&#x2010;CoV&#x2010;2 infection. Clin Pediatr. 2021;61:159&#x2010;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">34789028</ArticleId></ArticleIdList></Reference><Reference><Citation>Darabi A, Dehghanfard M, Jozan S, et al. Investigating the association between allergic diseases and COVID&#x2010;19 in 400 Iranian patients. Allergol Immunopathol. 2021;49(5):9&#x2010;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">34476916</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzan S, Rai S, Cerise J, et al. Asthma and COVID&#x2010;19: an early inpatient and outpatient experience at a US children's hospital. Pediatr Pulmonol. 2021;56(8):2522&#x2010;2529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242640</ArticleId><ArticleId IdType="pubmed">34062054</ArticleId></ArticleIdList></Reference><Reference><Citation>Geppe NA, Kolosova NG, Shakhnazarova MD, et al. COVID&#x2010;19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy. [Russian]. Ther Immunol. 2021;42(3):254&#x2010;260.</Citation></Reference><Reference><Citation>Metbulut AP, Mustafaoglu O, Sen G, et al. Evaluation of the clinical and laboratory findings of asthmatic children with SARS&#x2010;CoV&#x2010;2 infection. Int Arch Allergy Immunol. 2021;182(10):989&#x2010;996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339021</ArticleId><ArticleId IdType="pubmed">34167114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman J, Ballin M, Nordstrom A, Nordstrom P. Risk factors for COVID&#x2010;19 diagnosis, hospitalization, and subsequent all&#x2010;cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36(3):287&#x2010;298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946619</ArticleId><ArticleId IdType="pubmed">33704634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T, Pan J, Katikireddi SV, et al. Risk of COVID&#x2010;19 hospital admission among children aged 5&#x2010;17&#x2009;years with asthma in Scotland: a national incident cohort study. Lancet Respir Med. 2021;30:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631918</ArticleId><ArticleId IdType="pubmed">34861180</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoon JW, Grijalva CG, Thurm C, et al. Factors associated with COVID&#x2010;19 disease severity in US children and adolescents. J Hosp Med. 2021;16(10):603&#x2010;610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494279</ArticleId><ArticleId IdType="pubmed">34613896</ArticleId></ArticleIdList></Reference><Reference><Citation>Camiolo M, Gauthier M, Kaminski N, Ray A, Wenzel SE. Expression of SARS&#x2010;CoV&#x2010;2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype. J Allergy Clin Immunol. 2020;146(2):315&#x2010;324.e317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283064</ArticleId><ArticleId IdType="pubmed">32531372</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang EH, Willis AL, Romanoski CE, et al. Rhinovirus infections in individuals with asthma increase ACE2 expression and cytokine pathways implicated in COVID&#x2010;19. Am J Respir Crit Care Med. 2020;202(5):753&#x2010;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462393</ArticleId><ArticleId IdType="pubmed">32649217</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro&#x2010;Rodriguez JA, Forno E. Asthma and COVID&#x2010;19 in children: a systematic review and call for data. Pediatr Pulmonol. 2020;55(9):2412&#x2010;2418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323291</ArticleId><ArticleId IdType="pubmed">32558360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and COVID&#x2010;19 risk: a systematic review and meta&#x2010;analysis. Eur Respir J. 2022;59(3):2101209. doi:10.1183/13993003.01209-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01209-2021</ArticleId><ArticleId IdType="pmc">PMC8361304</ArticleId><ArticleId IdType="pubmed">34385278</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS&#x2010;CoV&#x2010;2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203&#x2010;206 e203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175851</ArticleId><ArticleId IdType="pubmed">32333915</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health O
. Essential health services face continued disruption during COVID&#x2010;19 pandemic; 2022. Accessed February 9, 2022. https://www.who.int/news/item/07&#x2010;02&#x2010;2022&#x2010;essential&#x2010;health&#x2010;services&#x2010;face&#x2010;continued&#x2010;disruption&#x2010;during&#x2010;covid&#x2010;19&#x2010;pandemic
</Citation></Reference><Reference><Citation>World Health O . The Impact of the COVID&#x2010;19 Pandemic on Noncommunicable Disease Resources and Services: Results of a Rapid Assessment. World Health Organization; 2020.</Citation></Reference><Reference><Citation>Papadopoulos NG, Custovic A, Deschildre A, et al. Impact of COVID&#x2010;19 on pediatric asthma: practice adjustments and disease burden. J Allergy Clin Immunol Pract. 2020;8(8):2592&#x2010;2599.e2593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297686</ArticleId><ArticleId IdType="pubmed">32561497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Del Rio P, Caimmi D, Rico P, et al. Real&#x2010;life report of allergen immunotherapy management during the COVID&#x2010;19 outbreak in France and Spain. Clin Exp Allergy. 2022;52(1):167&#x2010;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653094</ArticleId><ArticleId IdType="pubmed">34747540</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna MT, Beck S, Gribbin N, et al. The impact of COVID&#x2010;19 pandemic on adult and pediatric allergy &amp; immunology services in the UK National Health Service. J Allergy Clin Immunol Pract. 2021;9(2):709&#x2010;722.e702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703386</ArticleId><ArticleId IdType="pubmed">33271350</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A, Marriage D, Pur&#x2010;Ozyigit L, et al. National survey of allergen immunotherapy during the pandemic. Clin Exp Allergy. 2021;51(12):1658.</Citation></Reference><Reference><Citation>Chen G, DunnGalvin A, Campbell DE. Impact of COVID&#x2010;19 pandemic on quality of life for children and adolescents with food allergy. Clin Exp Allergy. 2022;52(1):162&#x2010;166. doi:10.1111/cea.13973</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13973</ArticleId><ArticleId IdType="pmc">PMC8444946</ArticleId><ArticleId IdType="pubmed">34157164</ArticleId></ArticleIdList></Reference><Reference><Citation>Westwell&#x2010;Roper C, To S, Soller L, Evelyn Stewart S, Chan ES. The impact of COVID&#x2010;19 on food&#x2010;allergy&#x2010;specific anxiety: a cross&#x2010;sectional survey of parents of children with food allergies. Allergy, Asthma and Clinical Immunology Conference: Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting, CSACI. 2020;17(Suppl 1).</Citation></Reference><Reference><Citation>Clawson AH, Nwankwo CN, Blair AL, Pepper&#x2010;Davis M, Ruppe NM, Cole AB. COVID&#x2010;19 impacts on families of color and families of children with asthma. J Pediatr Psychol. 2021;46(4):378&#x2010;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989447</ArticleId><ArticleId IdType="pubmed">33738483</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnik E, Foong RX, Batt R, et al. Trial of paediatric home allergy testing in response to COVID&#x2010;19 pandemic. Clin Exp Allergy. 2021;51(12):1683.</Citation></Reference><Reference><Citation>Nichols AL, Sonnappa&#x2010;Naik M, Gardner L, et al. COVID&#x2010;19 and delivery of difficult asthma services. Arch Dis Child. 2021;2:e15.</Citation><ArticleIdList><ArticleId IdType="pubmed">34728462</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Saleemi A, Farren L, McCarthy KF, et al. Management of anaphylaxis in children undergoing oral food challenges in an adapted COVID&#x2010;19 field hospital. Arch Dis Child. 2021;106(12):e52.</Citation><ArticleIdList><ArticleId IdType="pubmed">34433551</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne AM, Trujillo J, Fitzsimons J, et al. Mass food challenges in a vacant COVID&#x2010;19 stepdown facility: exceptional opportunity provides a model for the future. Pediatr Allergy Immunol. 2021;32(8):1756&#x2010;1763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420236</ArticleId><ArticleId IdType="pubmed">34152649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua GT, Chan ES, Soller L, Cook VE, Vander Leek TK, Mak R. Home&#x2010;based Peanut Oral immunotherapy for low&#x2010;risk Peanut&#x2010;allergic preschoolers during the COVID&#x2010;19 pandemic and beyond. Front Allergy. 2021;2:725165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8974914</ArticleId><ArticleId IdType="pubmed">35387028</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeta A, Takaoka Y, Nakano A, et al. Progress of home&#x2010;based food allergy treatment during the coronavirus disease pandemic in Japan: a cross&#x2010;sectional multicenter survey. Children (Basel). 2021;8(10):15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8535074</ArticleId><ArticleId IdType="pubmed">34682185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouis P, Michaelidou E, Kinni P, et al. Pediatric asthma symptom control during lockdown for the COVID&#x2010;19 pandemic in spring 2020: a prospective community&#x2010;based study in Cyprus and Greece. Pediatr Pulmonol. 2022;57(2):386&#x2010;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">34818465</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro L, Castagnoli R, Salemi C, Piacentini G, Pietrobelli A, Marseglia GL. The "stay at home" COVID&#x2010;19 lockdown restriction may have prevented asthma exacerbations in children affected by pollen allergy: a single center experience. Minerva Pediatr (Torino). 2021;14. doi:10.23736/S2724-5276.21</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S2724-5276.21</ArticleId><ArticleId IdType="pubmed">34647702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondi A, Betti L, Carbone C, et al. Understanding the environmental factors related to the decrease in pediatric emergency department referrals for acute asthma during the SARS&#x2010;CoV&#x2010;2 pandemic. Pediatr Pulmonol. 2022;57(1):66&#x2010;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661783</ArticleId><ArticleId IdType="pubmed">34606693</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera F, Berberian A, Cooley D, et al. Potential health benefits of sustained air quality improvements in new York City: a simulation based on air pollution levels during the COVID&#x2010;19 shutdown. Environ Res. 2021;193:110555.</Citation><ArticleIdList><ArticleId IdType="pubmed">33285156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Liu H, Shang S. Non&#x2010;pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID&#x2010;19 pandemic. J Infect. 2021;30:418&#x2010;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887997</ArticleId><ArticleId IdType="pubmed">34728266</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HG, Kong IG. Asthma, allergic rhinitis, and atopic dermatitis incidence in Korean adolescents before and after COVID&#x2010;19. J Clin Med. 2021;10(15):3446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347114</ArticleId><ArticleId IdType="pubmed">34362229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro VA, Zamunaro A, Spaggiari S, Di Riso D, Zanconato S, Carraro S. Pediatric asthma control during the COVID&#x2010;19 pandemic. Immun Inflamm Dis. 2021;9(2):561&#x2010;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014816</ArticleId><ArticleId IdType="pubmed">33657264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bover&#x2010;Bauza C, Gomila MAR, Perez DD, et al. The impact of the SARS&#x2010;CoV&#x2010;2 pandemic on the emergency department and management of the pediatric asthmatic patient. J Asthma Allergy. 2021;14:101&#x2010;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868176</ArticleId><ArticleId IdType="pubmed">33568921</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindisi G, De Vittori V, De Nola R, et al. Updates on children with allergic rhinitis and asthma during the covid&#x2010;19 outbreak. J Clin Med. 2021;10(11):2278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8197398</ArticleId><ArticleId IdType="pubmed">34073986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahal M, Amirav I, Diamant N, Be'er M, Besor O, Lavie M. Real&#x2010;time effects of COVID&#x2010;19 pandemic lockdown on pediatric respiratory patients. Pediatr Pulmonol. 2021;56(6):1401&#x2010;1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250588</ArticleId><ArticleId IdType="pubmed">33729709</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos NG, Mathioudakis AG, Custovic A, et al. Childhood asthma outcomes during the COVID&#x2010;19 pandemic: findings from the PeARL multi&#x2010;national cohort. Allergy. 2021;76(6):1765&#x2010;1775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013557</ArticleId><ArticleId IdType="pubmed">33608919</ArticleId></ArticleIdList></Reference><Reference><Citation>Taytard J, Coquelin F, Beydon N. Improvement in asthma symptoms and pulmonary function in children after SARS&#x2010;CoV&#x2010;2 outbreak. Front Pediatr. 2021;9:745611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569423</ArticleId><ArticleId IdType="pubmed">34746060</ArticleId></ArticleIdList></Reference><Reference><Citation>
GINA Global Strategy for Asthma Management and Prevention
. GINA guidance about COVID&#x2010;19 and asthma; 2022. Accessed February 21, 2022. https://ginasthma.org/wp&#x2010;content/uploads/2022/02/22_02_10&#x2010;GINA&#x2010;COVID&#x2010;19&#x2010;and&#x2010;asthma.pdf
</Citation></Reference><Reference><Citation>Maison N, Herbruggen H, Schaub B, et al. Impact of imposed social isolation and use of face masks on asthma course and mental health in pediatric and adult patients with recurrent wheeze and asthma. Allergy Asthma Clin Immunol. 2021;17(1):93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444172</ArticleId><ArticleId IdType="pubmed">34530911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Wang X, Wan XG, et al. Pediatric asthma control during the COVID&#x2010;19 pandemic: a systematic review and meta&#x2010;analysis. Pediatr Pulmonol. 2022;57(1):20&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662014</ArticleId><ArticleId IdType="pubmed">34672436</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsulaiman JW, Kheirallah KA, Ajlony MJ, Al&#x2010;Tamimi TM, Khasawneh RA, Al&#x2010;Natour L. Paediatric asthma exacerbation admissions and stringency of non&#x2010;pharmaceutical interventions: results from a developing country. Int J Clin Pract. 2021;75(9):e14423.</Citation><ArticleIdList><ArticleId IdType="pubmed">34076942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bun S, Kishimoto K, Shin JH, et al. Impact of the COVID&#x2010;19 pandemic on asthma exacerbations in children: a multi&#x2010;center survey using an administrative database in Japan. Allergol Int. 2021;70(4):489&#x2010;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282991</ArticleId><ArticleId IdType="pubmed">34281768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst JH, Zhao C, Fitzpatrick NS, Goldstein BA, Lang JE. Reduced pediatric urgent asthma utilization and exacerbations during the COVID&#x2010;19 pandemic. Pediatr Pulmonol. 2021;56(10):3166&#x2010;3173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441648</ArticleId><ArticleId IdType="pubmed">34289526</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper MP, Leva E, Trivedy P, Luckey J, Baker MD. Analysis of pediatric emergency department patient volume trends during the COVID&#x2010;19 pandemic. Medicine. 2021;100(27):e26583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270607</ArticleId><ArticleId IdType="pubmed">34232205</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SA, Quint JK, Nwaru BI, Sheikh A. Impact of COVID&#x2010;19 national lockdown on asthma exacerbations: interrupted time&#x2010;series analysis of English primary care data. Thorax. 2021;76(9):860&#x2010;866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011425</ArticleId><ArticleId IdType="pubmed">33782080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsenault S, Hoofman J, Poowuttikul P, Secord E. Sustained decrease in pediatric asthma emergency visits during the first year of the COVID&#x2010;19 pandemic. Allergy Asthma Proc. 2021;42(5):400&#x2010;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8677502</ArticleId><ArticleId IdType="pubmed">34474709</ArticleId></ArticleIdList></Reference><Reference><Citation>Attanasi M, Porreca A, Papa GFS, et al. Emergency department visits for allergy related&#x2010;disorders among children: experience of a single Italian hospital during the first wave of the COVID&#x2010;19 pandemic. Multidiscip Respir Med. 2021;16:786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524361</ArticleId><ArticleId IdType="pubmed">34745607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiapinotto S, Sarria EE, Mocelin HT, Lima JAB, Mattiello R, Fischer GB. Impact of non&#x2010;pharmacological initiatives for COVID&#x2010;19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr Respir Rev. 2021;39:3&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074521</ArticleId><ArticleId IdType="pubmed">34016531</ArticleId></ArticleIdList></Reference><Reference><Citation>Golan&#x2010;Tripto I, Arwas N, Maimon MS, et al. The effect of the COVID&#x2010;19 lockdown on children with asthma&#x2010;related symptoms: a tertiary care center experience. Pediatr Pulmonol. 2021;56(9):2825&#x2010;2832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441819</ArticleId><ArticleId IdType="pubmed">34126003</ArticleId></ArticleIdList></Reference><Reference><Citation>Krivec U, Kofol Seliger A, Tursic J. COVID&#x2010;19 lockdown dropped the rate of paediatric asthma admissions. Arch Dis Child. 2020;105(8):809&#x2010;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392481</ArticleId><ArticleId IdType="pubmed">32444452</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquechel K, Diwadkar AR, Sayed S, et al. Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID&#x2010;19 pandemic. J Allergy Clin Immunol Pract. 2020;8(10):3378&#x2010;3387.e3311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438361</ArticleId><ArticleId IdType="pubmed">32827728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich L, Macias C, George A, Bai S, Allen E. Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic. Pediatr Pulmonol. 2021;56(7):1951&#x2010;1956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251009</ArticleId><ArticleId IdType="pubmed">33848402</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Riso D, Spaggiari S, Cambrisi E, Ferraro V, Carraro S, Zanconato S. Psychosocial impact of Covid&#x2010;19 outbreak on Italian asthmatic children and their mothers in a post lockdown scenario. Sci Rep. 2021;11(1):9152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080660</ArticleId><ArticleId IdType="pubmed">33911108</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekliudov NA, Blyuss O, Cheung KY, et al. Excessive media consumption about COVID&#x2010;19 is associated with increased state anxiety: outcomes of a large online survey in Russia. J Med Internet Res. 2020;22(9):e20955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490003</ArticleId><ArticleId IdType="pubmed">32788143</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhawt M, Kimball S, DunnGalvin A, et al. Media influence on anxiety, health utility, and health beliefs early in the SARS&#x2010;CoV&#x2010;2 pandemic&#x2010;a survey study. J Gen Intern Med. 2021;36(5):1327&#x2010;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904294</ArticleId><ArticleId IdType="pubmed">33629267</ArticleId></ArticleIdList></Reference><Reference><Citation>Protudjer JLP, Golding M, Salisbury MR, Abrams EM, Roos LE. High anxiety and health&#x2010;related quality of life in families with children with food allergy during coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(1):83&#x2010;88.e81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498414</ArticleId><ArticleId IdType="pubmed">32950685</ArticleId></ArticleIdList></Reference><Reference><Citation>Yucel E, Suleyman A, Hizli Demirkale Z, Guler N, Tamay ZU, Ozdemir C. 'Stay at home': is it good or not for house dust mite sensitized children with respiratory allergies? Pediatr Allergy Immunol. 2021;32(5):963&#x2010;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">33604910</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Zeng Q, Tang Y, et al. Efficacy of sublingual immunotherapy in allergic rhinitis children during coronavirus disease 2019. Orl. 2021;83(6):428&#x2010;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450830</ArticleId><ArticleId IdType="pubmed">34510035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurley S, Franklin R, McCallion N, et al. Allergy&#x2010;related outcomes at 12 months in the CORAL birth cohort of Irish children born during the first COVID 19 lockdown. Pediatr Allergy Immunol. 2022;33(3):e13766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115474</ArticleId><ArticleId IdType="pubmed">35338733</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen AB, Ruge IF, Quaade AS, Johansen JD, Thyssen JP, Zachariae C. Increased occurrence of hand eczema in young children following the Danish hand hygiene recommendations during the COVID&#x2010;19 pandemic. Contact Dermatitis. 2021;84(3):144&#x2010;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">33085086</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M, Pawar M, Bothra A, Choudhary N. Overzealous hand hygiene during the COVID 19 pandemic causing an increased incidence of hand eczema among general population. J Am Acad Dermatol. 2020;83(1):e37&#x2010;e41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161474</ArticleId><ArticleId IdType="pubmed">32305441</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Washington Post
. Covid is making flu and other common viruses act in unfamiliar ways; 2022. Accessed August 23, 2022. https://www.washingtonpost.com/health/2022/06/13/covid&#x2010;flu&#x2010;rsv&#x2010;viruses/
</Citation></Reference><Reference><Citation>Burman J, Tanninen T, Makela MJ. The importance of telemedicine in the COVID&#x2010;era in the pediatric allergology unit. Allergy. 2021;76(Suppl 110):188&#x2010;189.</Citation></Reference><Reference><Citation>Kewalramani A, Waddell J, Puppa EL. Telemedicine during the coronavirus disease 2019 pandemic for pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2021;127(3):395&#x2010;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214811</ArticleId><ArticleId IdType="pubmed">34161830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragamin A, de Wijs LEM, Hijnen DJ, et al. Care for children with atopic dermatitis in The Netherlands during the COVID&#x2010;19 pandemic: lessons from the first wave and implications for the future. J Dermatol. 2021;48(12):1863&#x2010;1870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652427</ArticleId><ArticleId IdType="pubmed">34459024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk AB, Baccioglu A, Soyer O, Civelek E, Sekerel BE, Bavbek S. Change in allergy practice during the COVID&#x2010;19 pandemic. Int Arch Allergy Immunol. 2021;182(1):49&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649687</ArticleId><ArticleId IdType="pubmed">33059353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante G, Licari A, Marseglia GL, La Grutta S. Digital health interventions in children with asthma. Clin Exp Allergy. 2021;51(2):212&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753570</ArticleId><ArticleId IdType="pubmed">33238032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack DP, Hanna MA, Abrams EM, et al. Virtually supported home peanut introduction during COVID&#x2010;19 for at&#x2010;risk infants. J Allergy Clin Immunol Pract. 2020;8(8):2780&#x2010;2783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7284246</ArticleId><ArticleId IdType="pubmed">32534149</ArticleId></ArticleIdList></Reference><Reference><Citation>Noronha L, Leech S, Nicola B. An audit of the home food introduction service developed during the COVID&#x2010;19 pandemic. Clin Exp Allergy. 2021;51(12):1661&#x2010;1662.</Citation></Reference><Reference><Citation>Kouis P, Michanikou A, Anagnostopoulou P, et al. Use of wearable sensors to assess compliance of asthmatic children in response to lockdown measures for the COVID&#x2010;19 epidemic. Sci Rep. 2021;11(1):5895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971022</ArticleId><ArticleId IdType="pubmed">33723342</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimova PS, Namazova&#x2010;Baranova LS, Levina JG, Kalugina VG, Vishneva EA, Kharitonova EY. Mobile technologies in achieving and maintaining asthma control in children: first results of MedQuizBot chat bot. [Russian]. Pediatricheskaya Farmakologiya. 2021;18(3):214&#x2010;220.</Citation></Reference><Reference><Citation>Collins&#x2010;Hussey L, Jones C, Huntriss R. Do parents/carers of infants with non IgE&#x2010;mediated cow's milk protein allergy (CMPA) find smartphone&#x2010;delivered dietitian support acceptable and engaging? Clin Exp Allergy. 2021;51(12):1656.</Citation></Reference><Reference><Citation>Jain S, Thakur C, Kumar P, Goyal JP, Singh K. Telemedicine for asthma follow&#x2010;up in children during COVID&#x2010;19 pandemic. Indian J Pediatr. 2021;88(10):1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316109</ArticleId><ArticleId IdType="pubmed">34318408</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell E, Berk O, Smith W, et al. Patient, family and healthcare provider satisfaction with telemedicine in the COVID&#x2010;19 era. Clin Exp Allergy. 2021;51(12):1690&#x2010;1691.</Citation></Reference><Reference><Citation>Thomas I, Siew LQC, Rutkowski K. Synchronous telemedicine in allergy: lessons learned and transformation of care during the COVID&#x2010;19 pandemic. J Allergy Clin Immunol Pract. 2021;9(1):170&#x2010;176.e171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571459</ArticleId><ArticleId IdType="pubmed">33091636</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa SS, Vadamalai K, Ramsey A. Patient satisfaction with in&#x2010;person, video, and telephone allergy/immunology evaluations during the COVID&#x2010;19 pandemic. J Allergy Clin Immunol Pract. 2021;9(5):1858&#x2010;1863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857059</ArticleId><ArticleId IdType="pubmed">33548516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mac Mahon J, Hourihane JOB, Byrne A. A virtual management approach to infant egg allergy developed in response to pandemic&#x2010;imposed restrictions. Clin Exp Allergy. 2021;51(2):360&#x2010;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753832</ArticleId><ArticleId IdType="pubmed">33244828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeroushalmi S, Millan SH, Nelson K, Sparks A, Friedman AJ. Patient perceptions and satisfaction with teledermatology during the COVID&#x2010;19 pandemic: a survey&#x2010;based study. J Drugs Dermatol. 2021;20(2):178&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538563</ArticleId></ArticleIdList></Reference><Reference><Citation>Beebeejaun S, De Atouguia S, Shamsuddin M, Dhanapal S. Evaluating parental satisfaction with paediatric allergy telephone clinics during the COVID&#x2010;19 pandemic. Clin Exp Allergy. 2021;51(1):181.</Citation></Reference><Reference><Citation>Davies B, Kenia P, Nagakumar P, Gupta A. Paediatric and adolescent asthma: a narrative review of telemedicine and emerging technologies for the post&#x2010;COVID&#x2010;19 era. Clin Exp Allergy. 2021;51(3):393&#x2010;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013619</ArticleId><ArticleId IdType="pubmed">33527625</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID&#x2010;19 pandemic: an ARIA&#x2010;EAACI statement. Allergy. 2020;75(7):1546&#x2010;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264744</ArticleId><ArticleId IdType="pubmed">32329930</ArticleId></ArticleIdList></Reference><Reference><Citation>Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID&#x2010;19 pandemic: an EAACI statement. Allergy. 2020;75(11):2764&#x2010;2774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300800</ArticleId><ArticleId IdType="pubmed">32500526</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the current COVID&#x2010;19 pandemic: a position paper of AeDA, ARIA, EAACI, DGAKI and GPA: position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the swiss ARIA GroupC, German Society for Applied Allergology (AEDA)D, German Society for Allergology and Clinical Immunology (DGAKI)E, Society for Pediatric Allergology (GPA)F in cooperation with AG clinical immunology, allergology and environmental medicine of the DGHNO&#x2010;KHCG and the European academy of allergy and clinical immunology (EAACI)H . Allergol Select. 2020;4:44&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304289</ArticleId><ArticleId IdType="pubmed">32568272</ArticleId></ArticleIdList></Reference><Reference><Citation>
GINA Global Strategy for Asthma Management and Prevention
. GINA guidance about COVID&#x2010;19 and asthma; 2022. Accessed April 11, 2022. https://ginasthma.org/wp&#x2010;content/uploads/2022/02/22_02_10&#x2010;GINA&#x2010;COVID&#x2010;19&#x2010;and&#x2010;asthma.pdf
</Citation></Reference><Reference><Citation>Leonardi A, Salami E, Feuerman OM, Cavarzeran F. The effects of the COVID&#x2010;19 pandemic on the treatment of allergic eye diseases. Curr Opin Allergy Clin Immunol. 2021;21(5):500&#x2010;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9914169</ArticleId><ArticleId IdType="pubmed">34269742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1&#x2010;S55.</Citation><ArticleIdList><ArticleId IdType="pubmed">21122901</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and economic outcomes of home maintenance allergen immunotherapy in select patients with high health literacy during the COVID&#x2010;19 pandemic: a cost&#x2010;effectiveness analysis during exceptional times. J Allergy Clin Immunol Pract. 2020;8(7):2310&#x2010;2321.e2314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224677</ArticleId><ArticleId IdType="pubmed">32417446</ArticleId></ArticleIdList></Reference><Reference><Citation>Aytekin ES, Soyer O, Sekerel BE, Sahiner UM. Subcutaneous allergen immunotherapy in children: real life compliance and effect of COVID&#x2010;19 pandemic on compliance. Int Arch Allergy Immunol. 2021;182(7):631&#x2010;636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247823</ArticleId><ArticleId IdType="pubmed">33887728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaar O, Agache I, Bonini M, et al. COVID&#x2010;19 pandemic and allergen immunotherapy&#x2010;an EAACI survey. Allergy. 2021;76(11):3504&#x2010;3516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013670</ArticleId><ArticleId IdType="pubmed">33655519</ArticleId></ArticleIdList></Reference><Reference><Citation>Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M. Dupilumab and COVID&#x2010;19: what should we expect? Dermatol Ther. 2020;33(4):e13502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267436</ArticleId><ArticleId IdType="pubmed">32362061</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricozzi A, Talamonti M, De Simone C, et al. Management of patients with atopic dermatitis undergoing systemic therapy during COVID&#x2010;19 pandemic in Italy: data from the DA&#x2010;COVID&#x2010;19 registry. Allergy. 2021;76(6):1813&#x2010;1824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014537</ArticleId><ArticleId IdType="pubmed">34152613</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N, Damiani G, Watad A, et al. Higher rates of COVID&#x2010;19 but less severe infections reported for patients on Dupilumab: a big data analysis of the World Health Organization VigiBase. Eur Rev Med Pharmacol Sci. 2021;25(18):5865&#x2010;5870.</Citation><ArticleIdList><ArticleId IdType="pubmed">34604979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel K, Patruno C, Antonelli E, et al. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32&#x2010;week real&#x2010;world experience during the COVID&#x2010;19 pandemic. Clin Exp Dermatol. 2021;47:165&#x2010;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444687</ArticleId><ArticleId IdType="pubmed">34309892</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Poel LA, SoniTricker A, Bassou M, et al. Patient experience of a home omalizumab service in a paediatric tertiary referral for chronic urticaria (CU) setting&#x2010;a pilot study. Clin Exp Allergy. 2021;51(12):1695.</Citation></Reference><Reference><Citation>Makhecha S, Jamalzadeh A, Irving S, et al. Paediatric severe asthma biologics service: from hospital to home. Arch Dis Child. 2021;106(9):900&#x2010;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380910</ArticleId><ArticleId IdType="pubmed">33589471</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon&#x2010;Abarca JA. Obesity and immunodeficiencies are the main pre&#x2010;existing conditions associated with mild to moderate COVID&#x2010;19 in children. Pediatr Obesity. 2020;15(12):e12713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435515</ArticleId><ArticleId IdType="pubmed">32789994</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Yazidi LS, Al Rawahi H, Al Busaidi I, Al TS. Covid&#x2010;19 and primary immunodeficiency: one&#x2010;year experience. J Paediatr Child Health. 2021;57(4):594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206849</ArticleId><ArticleId IdType="pubmed">33751684</ArticleId></ArticleIdList></Reference><Reference><Citation>Castano&#x2010;Jaramillo LM, Yamazaki&#x2010;Nakashimada MA, O'Farrill&#x2010;Romanillos PM, et al. COVID&#x2010;19 in the context of inborn errors of immunity: a case series of 31 patients from Mexico. J Clin Immunol. 2021;41(7):1463&#x2010;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191444</ArticleId><ArticleId IdType="pubmed">34114122</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus N, Frizinsky S, Hagin D, et al. Minor clinical impact of COVID&#x2010;19 pandemic on patients with primary immunodeficiency in Israel. Front Immunol. 2020;11:614086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7840610</ArticleId><ArticleId IdType="pubmed">33519822</ArticleId></ArticleIdList></Reference><Reference><Citation>Milito C, Lougaris V, Giardino G, et al. Clinical outcome, incidence, and SARS&#x2010;CoV&#x2010;2 infection&#x2010;fatality rates in Italian patients with inborn errors of immunity. J Allergy Clin Immunol Pract. 2021;9(7):2904&#x2010;2906.e2902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8059325</ArticleId><ArticleId IdType="pubmed">33894392</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniawska&#x2010;smiech K, Kuraszewicz A, Sado J, Smiech K, Lewandowicz&#x2010;Uszynska A. Assessment of covid&#x2010;19 incidence and the ability to synthesise anti&#x2010;sars&#x2010;cov&#x2010;2 antibodies of paediatric patients with primary immunodeficiency. J Clin Med. 2021;10(21):5111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584568</ArticleId><ArticleId IdType="pubmed">34768630</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilla J, Guevara M, Miqueleiz A, et al. Risk factors of infection, hospitalization and death from SARS&#x2010;CoV&#x2010;2: a population&#x2010;based cohort study. J Clin Med. 2021;10(12):2608. doi:10.3390/jcm10122608</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122608</ArticleId><ArticleId IdType="pmc">PMC8231921</ArticleId><ArticleId IdType="pubmed">34199198</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudouris ES, Pinto&#x2010;Mariz F, Mendonca LO, et al. Outcome of SARS&#x2010;CoV&#x2010;2 infection in 121 patients with inborn errors of immunity: a cross&#x2010;sectional study. J Clin Immunol. 2021;41(7):1479&#x2010;1489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221557</ArticleId><ArticleId IdType="pubmed">34164762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho HE, Mathew S, Peluso MJ, Cunningham&#x2010;Rundles C. Clinical outcomes and features of COVID&#x2010;19 in patients with primary immunodeficiencies in new York City. J Allergy Clin Immunol Pract. 2021;9(1):490&#x2010;493.e492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543763</ArticleId><ArticleId IdType="pubmed">33039649</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields AM, Burns SO, Savic S, et al. COVID&#x2010;19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870&#x2010;875.e871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737531</ArticleId><ArticleId IdType="pubmed">33338534</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakoc Aydiner E, Bilgic Eltan S, Babayeva R, et al. Adverse COVID&#x2010;19 outcomes in immune deficiencies: inequality exists between subclasses. Allergy. 2022;77(1):282&#x2010;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441734</ArticleId><ArticleId IdType="pubmed">34314546</ArticleId></ArticleIdList></Reference><Reference><Citation>Delavari S, Abolhassani H, Abolnezhadian F, et al. Impact of SARS&#x2010;CoV&#x2010;2 pandemic on patients with primary immunodeficiency. J Clin Immunol. 2021;41(2):345&#x2010;355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707812</ArticleId><ArticleId IdType="pubmed">33263173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648&#x2010;656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577305</ArticleId><ArticleId IdType="pubmed">34734915</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. COVID&#x2010;19 vaccines for moderately or severely immunocompromised people; 2022. Accessed February 22, 2022. https://www.cdc.gov/coronavirus/2019&#x2010;ncov/vaccines/recommendations/immuno.html
</Citation></Reference><Reference><Citation>Topal OY, Metin A, Cop E, Dinc GS, Uneri OS. Anxiety among the parents of pediatric patients receiving ivig therapy during the covid&#x2010;19 pandemic. Turk J Pediatr. 2021;63(5):801&#x2010;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">34738362</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulvirenti F, Cinetto F, Milito C, et al. Health&#x2010;related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID&#x2010;19 pandemic. J Allergy Clin Immunol Pract. 2020;8(6):1894&#x2010;1899.e1892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195351</ArticleId><ArticleId IdType="pubmed">32278865</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreault S, Schiffer M, Clinchy&#x2010;Jarmoszko V, et al. Mitigating the risk of COVID&#x2010;19 exposure by transitioning from clinic&#x2010;based to home&#x2010;based immune globulin infusion. Am J Health Syst Pharm. 2021;78(12):1112&#x2010;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929449</ArticleId><ArticleId IdType="pubmed">33617630</ArticleId></ArticleIdList></Reference><Reference><Citation>Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Arch Dis Child. 2021;106:440&#x2010;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070630</ArticleId><ArticleId IdType="pubmed">33593743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha I, Bennett D, Taylor&#x2010;Robinson DC. Children are being sidelined by covid&#x2010;19. BMJ. 2020;369:m2061.</Citation><ArticleIdList><ArticleId IdType="pubmed">32461203</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Nations
. Policy brief: the impact of COVID&#x2010;19 on children; 2020. Accessed February 18, 2022. https://www.un.org/sites/un2.un.org/files/policy_brief_on_covid_impact_on_children_16_april_2020.pdf
</Citation></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez&#x2010;Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID&#x2010;19 pandemic. Lancet. 2020;395(10237):1607&#x2010;1608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334&#x2010;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS&#x2010;CoV&#x2010;2. Jama. 2020;324(3):259&#x2010;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan HA, Byrareddy SN. The potential threat of multisystem inflammatory syndrome in children during the COVID&#x2010;19 pandemic. Pediatr Allergy Immunol. 2021;32(1):17&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887110</ArticleId><ArticleId IdType="pubmed">32897642</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID&#x2010;19. Cell. 2020;183(4):968&#x2010;981. e967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K, Castagnoli R, Vakkilainen S, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID&#x2010;19. Nat Med. 2022;28:1050&#x2010;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9119950</ArticleId><ArticleId IdType="pubmed">35177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Dove ML, Jaggi P, Kelleman M, et al. Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management. J Pediatr. 2021;229:33&#x2010;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566788</ArticleId><ArticleId IdType="pubmed">33075369</ArticleId></ArticleIdList></Reference><Reference><Citation>McArdle AJ, Vito O, Patel H, et al. Treatment of multisystem inflammatory syndrome in children. N Engl J Med. 2021;385(1):11&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220965</ArticleId><ArticleId IdType="pubmed">34133854</ArticleId></ArticleIdList></Reference><Reference><Citation>Son MBF, Murray N, Friedman K, et al. Multisystem inflammatory syndrome in children &#x2013; initial therapy and outcomes. N Engl J Med. 2021;385(1):23&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220972</ArticleId><ArticleId IdType="pubmed">34133855</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin B, DeWitt PE, Russell S, et al. Characteristics, outcomes, and severity risk factors associated with SARS&#x2010;CoV&#x2010;2 infection among children in the US national COVID cohort collaborative. JAMA Netw Open. 2022;5(2):e2143151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826172</ArticleId><ArticleId IdType="pubmed">35133437</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1&#x2010;year outcomes in hospital survivors with COVID&#x2010;19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2010;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2010;mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405.</Citation><ArticleIdList><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP&#x2010;C . A clinical case definition of post&#x2010;COVID&#x2010;19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2010;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, et al. Long COVID (post&#x2010;COVID&#x2010;19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107:674&#x2010;680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long&#x2010;term COVID&#x2010;19 outcomes in children. JAMA Pediatr. 2021;175:1095&#x2010;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">34338711</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Simpson F, Mabbitt J, Dunn&#x2010;Galvin A, Semple C, Warner JO. Legacy of COVID&#x2010;19 infection in children: long&#x2010;COVID will have a lifelong health/economic impact. Arch Dis Child. 2022;107(3):e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34045207</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, et al. Persistent symptoms following SARS&#x2010;CoV&#x2010;2 infection amongst children and young people: a meta&#x2010;analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158&#x2010;170. doi:10.1016/j.jinf.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post&#x2010;COVID&#x2010;19 condition in previously hospitalised children using the ISARIC Global follow&#x2010;up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341. doi:10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et al. Physical and mental health 3 months after SARS&#x2010;CoV&#x2010;2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2010;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, et al. Prevalence and risk factors of post&#x2010;COVID&#x2010;19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID); 2022;20(1):244. doi:10.1186/s12916-022-02448-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID&#x2010;19. Clin Exp Allergy. 2021;51(9):1107&#x2010;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid&#x2010;19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F, Nguyen V, Navaratnam AM, et al. Prevalence of persistent symptoms in children during the COVID&#x2010;19 pandemic: evidence from a household cohort study in England and Wales. medRxiv. 2021. doi:10.1101/2021.05.28.21257602</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.21257602</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school&#x2010;aged children tested for SARS&#x2010;CoV&#x2010;2. Lancet Child Adolesc Health. 2021;5(10):708&#x2010;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>
The National Institute for Health and Care Excellence
. COVID&#x2010;19 rapid guideline: managing the longterm effects of COVID&#x2010;19; 2022. Accessed February 14, 2022. https://www.nice.org.uk/guidance/ng188/resources/covid19&#x2010;rapid&#x2010;guideline&#x2010;managing&#x2010;the&#x2010;longterm&#x2010;effects&#x2010;of&#x2010;covid19&#x2010;pdf&#x2010;51035515742
</Citation></Reference><Reference><Citation>Warner JO, Warner JA, Munblit D. Hypotheses to explain the associations between asthma and the consequences of COVID&#x2010;19 infection. Clin Exp Allergy. 2022;52(1):7&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34978737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn&#x2010;Ford S, Lunjani N, McSharry B, et al. Long&#x2010;term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS&#x2010;CoV&#x2010;2 infection. Allergy. 2021;76(9):2910&#x2010;2913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection in UK users of the COVID symptom study app: a prospective, community&#x2010;based, nested, case&#x2010;control study. Lancet Infect Dis. 2022;22(1):43&#x2010;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS&#x2010;CoV&#x2010;2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70(1):61&#x2010;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt CS, Siegrist CA. Is there a role for childhood vaccination against COVID&#x2010;19? Pediatr Allergy Immunol. 2021;32(1):9&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">33113210</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner PJ, Ansotegui IJ, Campbell DE, et al. COVID&#x2010;19 vaccine&#x2010;associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organ J. 2021;14(2):100517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857113</ArticleId><ArticleId IdType="pubmed">33558825</ArticleId></ArticleIdList></Reference><Reference><Citation>
U.S. Food and Drug Administration
. Coronavirus (COVID&#x2010;19) update: FDA authorizes Moderna and Pfizer&#x2010;BioNTech COVID&#x2010;19 vaccines for children down to 6 months of age; 2022. Accessed August 22, 2022. https://www.fda.gov/news&#x2010;events/press&#x2010;announcements/coronavirus&#x2010;covid&#x2010;19&#x2010;update&#x2010;fda&#x2010;authorizes&#x2010;moderna&#x2010;and&#x2010;pfizer&#x2010;biontech&#x2010;covid&#x2010;19&#x2010;vaccines&#x2010;children
</Citation></Reference><Reference><Citation>Gao P, Cai S, Liu Q, Du M, Liu J, Liu M. Effectiveness and safety of SARS&#x2010;CoV&#x2010;2 vaccines among children and adolescents: a systematic review and meta&#x2010;analysis. Vaccines (Basel). 2022;10(3):421. doi:10.3390/vaccines10030421</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10030421</ArticleId><ArticleId IdType="pmc">PMC8953823</ArticleId><ArticleId IdType="pubmed">35335053</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhawt M, Abrams EM, Shaker M, et al. The risk of allergic reaction to SARS&#x2010;CoV&#x2010;2 vaccines and recommended evaluation and management: a systematic review, meta&#x2010;analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract. 2021;9(10):3546&#x2010;3567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248554</ArticleId><ArticleId IdType="pubmed">34153517</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerji A, Wolfson AR, Wickner PG, et al. COVID&#x2010;19 vaccination in patients with reported allergic reactions: updated evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9(6):2135&#x2010;2138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049186</ArticleId><ArticleId IdType="pubmed">33866033</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush C, Faulk KE, Bradley ZK, Turner A, Krumins M, Greenhawt M. The safety of SARS&#x2010;CoV&#x2010;2 vaccines in persons with a known history of pegaspargase allergy: a single institution experience. J Allergy Clin Immunol Pract. 2022;10(2):630&#x2010;632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8648374</ArticleId><ArticleId IdType="pubmed">34883262</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo G, Anvari S, Friedman DL, et al. mRNA COVID&#x2010;19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase. J Allergy Clin Immunol Pract. 2022;10(1):322&#x2010;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8526431</ArticleId><ArticleId IdType="pubmed">34678498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark C, Gupta S, Punnett A, et al. Safety of administration of BNT162b2 mRNA (Pfizer&#x2010;BioNTech) COVID&#x2010;19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG&#x2010;asparaginase. Pediatr Blood Cancer. 2021;68(11):e29295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441639</ArticleId><ArticleId IdType="pubmed">34398511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu DK, Abrams EM, Golden DBK, et al. Risk of second allergic reaction to SARS&#x2010;CoV&#x2010;2 vaccines: a systematic review and meta&#x2010;analysis. JAMA Intern Med. 2022;182(4):376&#x2010;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861900</ArticleId><ArticleId IdType="pubmed">35188528</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>